Casanova, Alexandre G.
Roth, Gael S.
Hausmann, Simone
Lu, Xiaoyin http://orcid.org/0000-0002-9244-325X
Bischoff, Ludivine J. M.
Froeliger, Emilie M.
Belmudes, Lucid
Bourova-Flin, Ekaterina
Flores, Natasha M.
Benitez, Ana Morales
Chasan, Tourkian
Caporicci, Marcello
Vayr, Jessica http://orcid.org/0000-0001-9821-3589
Blanchet, Sandrine
Ielasi, Francesco
Rousseaux, Sophie http://orcid.org/0000-0001-5246-5350
Hainaut, Pierre
Gozani, Or http://orcid.org/0000-0002-1365-4463
Le Romancer, Muriel
Couté, Yohann http://orcid.org/0000-0003-3896-6196
Palencia, Andres
Mazur, Pawel K. http://orcid.org/0000-0002-5820-8344
Reynoird, Nicolas http://orcid.org/0000-0003-1578-2781
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-15-IDEX-02)
Institut National Du Cancer (INCA_ 16066)
Ligue Contre le Cancer
GEFLUC
Fondation pour la Recherche Médicale (ECO20170637491)
Fondation ARC pour la Recherche sur le Cancer
Institut National de la Santé et de la Recherche Médicale
U.S. Department of Health & Human Services | National Institutes of Health (K99 CA255936, R01CA236118, R01CA236949, R01CA278940, R01CA272844, R01CA266280, R01CA272843)
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Health & Human Services | National Institutes of Health
U.S. Department of Defense (CA181486)
Cancer Prevention and Research Institute of Texas (RP220391, RR160078)
Article History
Received: 9 May 2023
Accepted: 13 December 2023
First Online: 31 January 2024
Change Date: 26 March 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41421-024-00661-4
Conflict of interest
: P.K.M. is a scientific co-founder, consultant and stockholder of Amplified Medicines, Inc. and Ikena Oncology, Inc.